InfuCare Rx is pleased to announce its selection as a limited distribution provider of VYVGART™. VVGART™ has been approved by the Food & Drug Administration (FDA) in the treatment of generalized myasthenia gravis (gMG) in adults who test positive for the antiacetylcholine receptor (AChR) antibody.
InfuCare Rx is a leading data-driven nationwide specialty infusion provider. We focus on treating patients with complex conditions who require comprehensive clinical management services. Many chronic conditions require specialized infusion therapies to help patients lead a healthy and productive lifestyle. InfuCare Rx provides a consistent and coordinated infusion experience for patients in the convenience of their home or alternate care setting. Our dedicated team of pharmacists, nurses, and other trained professionals strive to provide optimal patient outcomes through cost-effective, patient-specific services.